Projected to grow from US$3.92 billion in 2024 to US$20.84 billion by 2033 at 20.6% CAGR, the obesity therapeutics market thrives on Takeda and KVK Tech innovations. Dive into segmentation by drug class, regional surges, and challenges in high-growth chronic care. https://finance.yahoo.com/news/competitive-landscape-obesity-therapeutics-market-141800112.html